MOTT as a cause of treatment failure in pulmonary tuberculosis

R. Elhefny, H. Abo Youssif, Y. Akl, N. Nawar (Fayoum, Cairo, Egypt)

Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Session: Non-tuberculous mycobacteria: clinical management
Session type: Thematic Poster Session
Number: 4415
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Elhefny, H. Abo Youssif, Y. Akl, N. Nawar (Fayoum, Cairo, Egypt). MOTT as a cause of treatment failure in pulmonary tuberculosis. Eur Respir J 2013; 42: Suppl. 57, 4415

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015

Experience of using diaskintest in adult patients with tuberculosis and non-tuberculosis respiratory diseases in a regional TB hospital
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013


Link between clinical severity of osteoarticular tuberculosis and the combined presence of pulmonary tuberculosis
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016

Two case reports: The successful management of pulmonary mycobacterium bohemicum
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Predictive factors of recurrent pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014


The feature of BCG complications in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Features of pulmonary tuberculosis in migrants
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015

Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Why do we need a classification of urogenital tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016

Range of additional drug resistance of M.tuberculosis in XDR-TB patients
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


Risk factors for acquired drug-resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013

Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015

Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Modern social and clinical characteristics of miliary tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


Mutations in the genes of drug-resistant mycobacterium tuberculosis in Uzbekistan
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014